Latest filing published 16 Jun 2015 for Arena Pharmaceuticals INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +9.8%Entry US$327,687.50 · Close at T+365 US$359,843.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harry F. Hixson Jr.: trading record in brief
This profile gathers the share dealings of Harry F. Hixson Jr. across 3 companies, led by Stablecoin Development Corp, Sequenom Inc and Arena Pharmaceuticals Inc. We count 37 filings; the first trade dates from 10 June 2008 and the latest from 12 June 2015.
The open-market side counts 5 purchases for €495k alongside 1 sale for €169k. Taken together, the purchases exceed the sales by €326k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 26 share grants and 4 option exercises.
The median purchase comes to €119k.
Most recently, on 16 June 2015, the filings show a share grant in Arena Pharmaceuticals Inc. The last purchase on record was published on 2 August 2012, which is 5,212 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Harry F. Hixson Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,145 shares0Common StockSEC:0001170362-15-000003:0
- 20,438 shares0Common StockSEC:0001193614-15-000018:0
- 40,500 shares0Common StockSEC:0001193614-15-000018:1
- 25,384 shares0Common StockSEC:0001170362-14-000008:0
- 25,000 shares@ US$4.11Common StockSEC:0001170362-14-000005:0
- 11,900 shares@ US$4.11Common StockSEC:0001170362-14-000005:1
- 36,900 shares@ US$6.31Common StockSEC:0001170362-14-000005:2
- 20,438 shares0Common StockSEC:0001182615-14-000042:0
- 8,946 shares@ US$2.34Common StockSEC:0001182615-14-000042:1
- 75,000 shares0Common StockSEC:0001321466-13-000086:0
- 28,185 shares@ US$4.22Common StockSEC:0001321466-13-000086:1
- 18,728 shares0Common StockSEC:0001170362-13-000002:0
- 50,000 shares@ US$2.92Common StockSEC:0001241032-12-000006:0Canonical exit: 30 Oct 2012 (T+90)
- 10,001 shares0Common StockSEC:0001454522-12-000013:0
- 10,001 shares0Common StockSEC:0001454522-12-000013:1
- 2,499 shares0Common StockSEC:0001454522-12-000013:2
- 50,000 shares@ US$4.19Common StockSEC:0001454522-11-000026:0Canonical exit: 14 Feb 2012 (T+90)
- 12,498 shares0Common StockSEC:0001454522-11-000014:0
- 685 shares0Common StockSEC:0001474649-10-000014:0
- 343 shares0Common StockSEC:0001140361-09-022801:0
- 1,350 shares0Common StockSEC:0001140361-09-021077:0
- 1,459 shares0Common StockSEC:0001140361-09-021078:0
- 252 shares0Common StockSEC:0001140361-09-019003:0
- 25,000 shares@ US$2.33Common StockSEC:0001140361-09-014682:0Canonical exit: 9 Sept 2009 (T+90)
- 1,369 shares0Common StockSEC:0001140361-09-014197:0
25 of 37 declarations
